Hypoglycaemia in patients with diabetes can be induced by insulins and sulfonylureas. We assessed the real‐world impact of specific monotherapy and combination regimens on hypoglycaemic events requiring hospitalisation and related… Click to show full abstract
Hypoglycaemia in patients with diabetes can be induced by insulins and sulfonylureas. We assessed the real‐world impact of specific monotherapy and combination regimens on hypoglycaemic events requiring hospitalisation and related secondary costs to the English healthcare system.
               
Click one of the above tabs to view related content.